ACRC Trials

Name

ACRC Trials

Legal name

ACRC Trials

Website

https://acrctrials.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAI

Patient Recruitment, Site Feasibility & Trial Enablement CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGACAC

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Clinical trial services
• Investigator site network
• Vaccine clinical trials
• Therapeutic clinical research
• Phase I-IV trials

Headquarters

HQ city

Plano

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Trial Services for Sponsors and CROs: ACRC Trials generates revenue by conducting Phase I, II, III, and IV outpatient clinical trials for pharmaceutical sponsors and contract research organizations (CROs). Services include rapid study start-up, subject enrollment, quality assurance, and site operations. The company delivers high-quality clinical data on time with full regulatory compliance.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

ACRC Trials is a Texas-based clinical research investigator site network that conducts outpatient Phase I, II, III, and IV clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs). The company recruits adult and pediatric participants from its Texas communities for vaccine and therapeutic studies, and executes study protocols with rapid start-up, regulatory compliance, and centralized digital data capture.

Product overview

ACRC Trials is a clinical research site network (established 2005/2006) offering adult and pediatric clinical trials across Texas. The company operates multiple research sites in Plano, Carrollton, Frisco, Grapevine, Austin, and Houston. Their core service is conducting clinical trials encompassing two main categories: Vaccine Clinical Trials (COVID-19, flu, RSV, norovirus, MMR, chickenpox, HPV, CMV, meningitis, UTI, and pediatric vaccines) and Therapeutic Studies (weight loss/GLP-1, chronic gout, male pattern baldness, contraceptive patch, hypertension, and other conditions). The company also provides clinical trial services for sponsors and CROs across Phase I-IV outpatient trials with digital technology including e-source, e-regulatory, CTMS, and remote monitoring capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Services (Phase I-IV outpatient trials for sponsors and CROs) Outpatient clinical trial execution service for pharmaceutical sponsors and CROs, covering Phase I, II, III, and IV studies, including rapid study start-up, subject enrollment, regulatory compliance (FDA, IRB, GCP), quality assurance, and site operations with centralized digital data capture.
• Vaccine Clinical Trials Clinical trials evaluating investigational vaccines, including COVID-19, flu, RSV, norovirus, MMR, chickenpox, HPV, CMV, meningitis, pneumococcal, and UTI vaccines, for adult and pediatric participants across Texas locations.
• Weight Loss Study (GLP-1/GIP) Clinical study evaluating a subcutaneous GLP-1/GIP combination medication for obesity and overweight adult participants.
• Chronic Gout Study (REDUCE-1) Investigational study drug trial for chronic gout targeting reduction and prevention of tophi in adult participants.
• Androgenic Alopecia (Male Pattern Hair Loss) Study Multi-center, randomized, double-blinded clinical trial evaluating a new non-hormonal oral tablet treatment for pattern hair loss (androgenic alopecia) in men, conducted in partnership with Verademics.
• Contraceptive Birth Control Patch Study Clinical trial evaluating a next-generation hormonal birth control patch that delivers hormones transdermally as an alternative to oral contraceptives.
• Adults COVID-19 Vaccine Study COVID-19 vaccine clinical trial for adults ages 50-64, evaluating an investigational vaccine for protection against COVID-19.
• Pediatric COVID-19 Vaccine Study COVID-19 vaccine clinical trial for children ages 5-11 focused on vaccine safety, tolerability, and immune response.
• Norovirus Vaccine Study Clinical trial evaluating an investigational norovirus (stomach bug) vaccine in adults 60 and older.
• Adult RSV Vaccine Study Clinical trial evaluating a respiratory syncytial virus (RSV) vaccine for adult participants.
• Hypertension (High Blood Pressure) Study Clinical study for adults with uncontrolled high blood pressure evaluating new treatment approaches.

Quantifiable outcome

• Over 20 years of experience conducting ethical and reliable clinical trials
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core and minor.

• VerademicscoreStrategic or Co-development PartnerVerademics is working with doctors at ACRC Trials to investigate a new, non-hormonal, oral treatment for pattern hair loss (androgenic alopecia). This is a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
• Pharmaceutical SponsorscoreStrategic or Co-development PartnerPharmaceutical companies engage ACRC Trials to conduct Phase I, II, III, and IV clinical trials for their investigational medications and vaccines. ACRC delivers high-quality data with rapid study start-up and strong patient enrollment.
• Contract Research Organizations (CROs)coreStrategic or Co-development PartnerCROs partner with ACRC Trials to execute clinical trial protocols across multiple therapeutic areas. The company provides site management, patient recruitment, and data collection services.
• Institutional Review Boards (IRBs)coreOthersAll studies are reviewed by an Institutional Review Board (IRB)/ Ethics Committee (EC) to protect the rights, safety, and well-being of study participants. IRBs provide independent ethical oversight of clinical research.
• Central IRBminorOthersACRC Trials utilizes Central IRB for efficient regulatory review and approval of multi-site clinical trials.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Benchmark Research: Benchmark Research operates multiple clinical research sites across Texas and the South, conducting vaccine and therapeutic trials with their own patient database — a direct regional comparable to ACRC.
• Velocity Clinical Research: Velocity is one of the largest integrated clinical research site networks in the U.S., operating outpatient Phase I–IV trials across multiple therapeutic areas — directly comparable to ACRC's investigator site model, with a substantially larger geographic footprint.
• Celerion: Celerion operates early-phase clinical research units and site networks serving pharmaceutical sponsors globally, overlapping with ACRC's Phase I–IV outpatient trial capability and sponsor-customer base.
• DM Clinical Research: DM Clinical Research is a Texas-headquartered investigator site network conducting multi-therapeutic outpatient Phase I–IV trials — overlapping directly with ACRC's Texas footprint and therapeutic mix.
• Meridien Research: Meridien Research operates multiple outpatient clinical research sites across the southeastern U.S. conducting Phase II–IV trials, directly comparable in scale and therapeutic focus to ACRC.
• Synexus (Accelerated Enrollment Solutions): Synexus/AES is one of the world's largest dedicated clinical trial site networks, running multi-therapeutic outpatient studies with proprietary patient databases — a comparable site-network model to ACRC.
• Javara Research: Javara is an integrated clinical research organization embedded within large medical practices, conducting Phase I–IV trials across therapeutic areas — comparable business model to ACRC's site network approach.

Broad incumbents

• PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher Scientific, is a top global CRO with embedded clinical research sites and site-management services — a broad incumbent counterpart to independent site networks like ACRC.
• ICON plc: ICON is one of the largest global CROs and acquired PRA Health Sciences, including site-management capabilities; it is a sponsor-side partner and partial competitor to ACRC via its embedded site services.
• Labcorp Drug Development (Fortrea): Fortrea (spun out from Labcorp) is a global CRO offering site-management and clinical trial services to sponsors — a broader incumbent that competes with and partners alongside independent sites like ACRC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/quiznos-sub

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACRC Trials